Assessment of the clinical impact of related (clonal) Pseudomonas aeruginosa strains in people with cystic fibrosis (CF).

Not Applicable

Recruiting

• Conditions: Clonal P. aeruginosa infection in patients with cystic fibrosis.; Infection - Studies of infection and infectious agents; Human Genetics and Inherited Disorders - Cystic fibrosis

• Registration Number: ACTRN12607000349448
• Lead Sponsor: A/Prof Scott Bell (Principle Investigator)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-06-28
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 1500

Inclusion Criteria

Children, adolescents and adults (both males and females) with CF who can produce a spontaneously expectorated sputum sample with evidence of P. aeruginosa (this will apply to both the Prevalence and Observational Studies). 2) Following the Cross sectional Study, only those patients without evidence of clonal strains will continue to have samples and clinical data collected for the Observational Study.

Exclusion Criteria

1) Patient's that are unable to produce a spontaneously expectorated sputum sample or those who have no evidence of P. aeruginosa. 2) Patient's with evidence of a clonal strain at the completion of the Prevalence Study, will not be included in the Observational Study. 3) Any patient that is unable or unwilling to provide written informed consent.

Study & Design

• Study Type: Observational
• Study Design: Not specified